What is the malignancy risk of neurofibromas?

Updated: Jan 30, 2020
  • Author: Ginard I Henry, MD; Chief Editor: Gregory Gary Caputy, MD, PhD, FICS  more...
  • Print


Individuals with NF-1 harbor a 7–13% lifetime risk of developing a malignant peripheral nerve sheath tumor, which usually arises in preexisting plexiform or focal subcutaneous neurofibromas. Using the normal clinical signs to evaluate for a potential malignant or transforming premalignant lesion is challenging. In patients with NF-1, new lesions develop and grow continually, so close surveillance is recommended. Neurofibroma can occur in major peripheral nerves, which can cause disruption of nerve function. [24] Neurofibromas commonly occur within the substance of the nerve, which creates a severe challenge to remove the tumor without causing further nerve dysfunction. Internal neurolysis and nerve grafting are performed as indicated for neurofibromas resection.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!